Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex
Patent
1997-08-25
2000-07-11
Lankford, Jr., Leon B.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Conjugate or complex
514 27, A61K 3578, A61K 3170
Patent
active
06086883&
ABSTRACT:
Extracts of leaves of Ginkgo biloba contain at least 25% glycolipids by weight, preferably at least 1% cerebrosides including galactocerebroside. The extract has less than 50 ppm of ginkgolic acid. The extract is prepared by recovering a lipid fraction which is mixed with alcohol providing an alcoholic medium. The alcoholic medium is treated in a chromatographic column with a mixture of acetone and toluene to remove neutral lipids and ginkgolic acid, and subsequently the alcoholic solution in the column is further treated with a mixture of acetone and water to extract the glycolipids. The extracts have shown activity in cosmetic and skin care applications.
REFERENCES:
patent: 4886904 (1989-12-01), Tanaka et al.
patent: 5389370 (1995-02-01), O'Reilly et al.
patent: 5512286 (1996-04-01), Schwabe
O'Reilly Annual Proc. Phytochem. Soc. of Europe, 1993 pp. 253-270.
Database WPI Section Ch, Week 8810, Derwent Pub., Ltd., London GB, JP,A,63 021 061, Jan. 28, 1988.
Patent Abstracts of Japan, vol. 012, No. 139, Apr. 27, 1988 & JP,A,62 255 433, Nov. 7, 1987.
Lankford , Jr. Leon B.
Montana Limited
Tate Christopher R.
LandOfFree
Extract from the leaves of Ginkgo biloba does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Extract from the leaves of Ginkgo biloba, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Extract from the leaves of Ginkgo biloba will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-539272